FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

444627005: OnabotulinumtoxinA (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2869585015 OnabotulinumtoxinA (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2872774015 OnabotulinumtoxinA en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
7527891000241113 onabotulinumtoxinA fr Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
OnabotulinumtoxinA (substance) Is a Botulinum toxin type A false Inferred relationship Some
OnabotulinumtoxinA (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that is produced by a living organism and is toxic, noxious, or poisonous. true Inferred relationship Some
OnabotulinumtoxinA (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Ganglion blocker true Inferred relationship Some
OnabotulinumtoxinA (substance) Is a Botulinum toxin type A and/or botulinum toxin type A derivative true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
OnabotulinumtoxinA 100unit injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False OnabotulinumtoxinA (substance) Inferred relationship Some
Product containing only onabotulinumtoxinA (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing onabotulinumtoxinA (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True OnabotulinumtoxinA (substance) Inferred relationship Some 1
OnabotulinumtoxinA only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True OnabotulinumtoxinA (substance) Inferred relationship Some 1
OnabotulinumtoxinA-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 200 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 200 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 100 unit/1 vial powder for conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True OnabotulinumtoxinA (substance) Inferred relationship Some 1
Product containing precisely onabotulinumtoxinA 100 unit/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True OnabotulinumtoxinA (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start